Watch Wedge Industrial Co Ltd for free: we tell you when fair value or trend changes.

Wedge Industrial Co Ltd (000534) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Wedge Industrial Co Ltd stock ¥6.97, price ¥17.14, that is 59.3% below the price, quality 42 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

16 models, one by oneBear ¥4.82 to bull ¥9.26 Growth analysisrevenue history, year by year Quality 42/100 in detail37 factors, each one shown Compared with its peersrank on every measure, side by side

Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare CN · ISIN CNE0000004T4

Some data Nov 5, 2026

Wedge Industrial Co Ltd

000534 · SHE

Very expensive, weak quality

Our calculation puts a fair price 59% below what the stock costs today.

Solidly profitable · 15.2% net margin (TTM)

Quality 42/100

Mixed Growth (revenue 5y +14.5 %/yr in CNY)

Moderate debt

Mixed vs. peers (6/14)

Moderate moat 52/100 · thin data

Some data

Fair value ¥6.97 · Strongly overvalued (−59.3%)

Negative free cash flow

Watch Wedge Industrial Co Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.

How to read this chart

60‑month range ¥8.66 – ¥47.65 · fair‑value band ¥4.82 – ¥9.26 · the ¥17.14 price screens above the ¥6.97 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.

Follow Wedge Industrial Co in your weekly email

Every Wednesday you see whether Wedge Industrial Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Wedge Industrial Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of micro-ecological live bacteria products, superalloys, and related products in China.

Show moreShow less

The company offers micro-ecological preparations, such as bifidobacterium lactobacillus triple live bacteria tablets under the Golden Bifidobacterium brand; vaginal lactobacillus live capsules under the Dingjunsheng brand; dual-span microecological live bacteria drugs under the Jinshuangqi brand; and vaginal microecological live bacteria drug for use in the treatment of gynecological infections under the Dingjunsheng brand.

It also provides probiotic products, health food products, probiotic dietary supplements, probiotic hand creams, and other probiotic health products under the Sanlian Probiotics, Bacteria powder, and Today's Bacteria brands.

In addition, the company is involved in the research, development, and manufacture of high-temperature alloy materials and core components, including precision casting blades, high temperature alloy powder discs, high temperature master alloys and their alloy powders, and nickel-based high-temperature master alloys.

Wedge Industrial Co.,Ltd. was formerly known as Guangdong Wanze Industrial Co., Ltd. and changed its name to Wedge Industrial Co., Ltd. in May 2013. The company was founded in 1992 and is based in Shantou, China.

Stock analysis

Wedge Industrial Co Ltd (000534) currently trades at ¥17.14, while our model-based Fair Value estimate is ¥6.97, 59% below the price, so the stock looks overvalued today.

Valuation

Bull case: the Growth Earnings group reads highest at a median of ¥7.90 per share, and 0 of the 16 models we run sit above the ¥17.14 price.

Bear case: the Asset-Based group reads lowest at ¥1.27, and 16 of the 16 models stay below the price. Data coverage for this calculation is medium.

Scenario range: ¥4.82 (bear) to ¥9.26 (bull), the price of ¥17.14 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 42/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Wedge Industrial Co Ltd reported revenue of 1.1B CNY in FY2024 versus 553M CNY in FY2020, a compound +18.2%/yr. Reported net income was 193M CNY in FY2024, compounding +25.9%/yr from FY2020.

Key figures

Market cap 8.8B CNY (≈ $1.3B) Small · P/E ratio 43.9 · P/S ratio 6.59 · EPS (TTM) ¥0.3900 · Net margin 15.2% · Return on equity 9.1% · Return on assets (EBIT) 5.9% (5-year average) · Operating margin 14.9%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 64% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at −59%, 000534 screens richer than that median.

Fair Value models

Bear ¥4.82 Fair Value ¥6.97 Bull ¥9.26

Price ¥17.14 · Downside -59.3%

Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2024 figures (about 12 months old). Earnings retained since then (¥0.3900 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.

Best data coverage

Residual Income ¥2.51 ¥2.98 ¥3.93 76

EPV ¥1.64 ¥2.08 ¥2.45 74

ROIC Compounder ¥1.64 ¥2.08 ¥2.45 72

All 16 models by family

Earnings-Based

Graham-Dodd ¥2.57 ¥13.13 ¥18.14 64

Lynch FV ¥3.57 ¥5.11 ¥6.64 61

PEG = 1.0 ¥3.57 ¥5.11 ¥6.64 57

EPV ¥1.64 ¥2.08 ¥2.45 74

Dividend Discount

Gordon GGM ¥1.88 ¥3.52 ¥4.99 67

DDM Multi-Stage ¥1.88 ¥3.15 ¥3.74 67

Multiples

P/E Multiple ¥6.24 ¥8.32 ¥10.40 63

P/S Multiple ¥4.82 ¥6.43 ¥8.04 58

P/B Multiple ¥6.37 ¥8.50 ¥10.62 55

EV/EBIT ¥3.41 ¥5.27 ¥7.14 65

EV/EBITDA ¥4.68 ¥6.97 ¥9.26 66

EV/Revenue ¥1.81 ¥3.52 ¥5.23 51

Asset-Based

NCAV (Graham) ¥0.9400 ¥1.27 ¥1.89 54

Economic Profit

Residual Income ¥2.51 ¥2.98 ¥3.93 76

ROIC Compounder ¥1.64 ¥2.08 ¥2.45 72

Growth Earnings

Growth-Adj P/E ¥5.53 ¥7.90 ¥10.28 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 42/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 44

How much profit the company makes from its sales and capital

Quality Growth 41

Are margins and returns getting better?

Cashflow 13

Do the profits arrive as real cash?

Financial strength 56

Debt, balance sheet and risk of trouble

Investment 20

Does it invest with discipline instead of growing at any price?

Low Volatility 50

How calm the share price moves, does not count

Price momentum 24

Price momentum of the last 3 to 12 months, does not count

Near the 52-week high 22

Distance to the 52-week high, does not count

New shares 79

Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 49/100

Revenue is growing, but margins or cash flow do not fully confirm the trend.

Revenue growth 1 year

+9.9%

Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+18.0%

Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+14.5%

Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.

+9.5%

’13

’14

’15

’16

’17

’18

’19

’20

’21

’22

’23

’24

What shareholders gained per year (last 5 years) (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip.

+21.5%

Earnings growth per share plus dividend.

Earnings per share, growth per year+21.5%

Dividend (yield on the price)0.0%

Per share before 2006divided by the spin-off factor 1.531

Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.19.3% vs 14.2%, picking up

Profit margin 2019 to 2024 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 21%

2024 sits 88% above its own trend. The rate follows the median trend of the last 5 years, not that single year.

000534 screens overvalued: fair value 59% below the price. Compare with Merck KGaA →

Compare Wedge Industrial Co Ltd with another stock

Price, fair value, quality and upside side by side.

First stock

Second stock

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 549 stocks

Beats the industry median on 6/14 measures

A mixed picture versus its industry peers.

Valuation

Quality Score 42 · Bottom 25%

Fair Value upside −59.3% · Bottom 25%

Profitability

Return on equity (12 months) 9.1% · Above median

Return on assets 4.9% · Above median

Net margin (12 months) 15.2% · Top 25%

Operating margin (12 months) 14.9% · Above median

Growth and dividend

Revenue growth (quarter YoY) 5.7% · Above median

Dividend yield (12 months) 0.0% · Bottom 25%

Balance sheet

Debt / equity 0.81× · Highest 25%

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/E (12 months) 43.9× · Priciest 25%

P/B 6.45× · Priciest 25%

P/S (12 months) 6.59× · Priciest 25%

EV/EBITDA 34.9× · Priciest 25%

PEG 0.94× · Cheaper than median

Strength profile in five axes (Snowflake)

This stock

Sector peers

VALUE (fair-value potential)0 · sector 15

FUTURE (revenue growth)29 · sector 25

PAST (return on equity)36 · sector 29

HEALTH (low debt)60 · sector 96

DIVIDEND (yield)0 · sector 32

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock	Price	Fair Value	vs Fair Value	Compare
Zoetis Inc ZTS	$79.40	$111.63	+41%	vs 000534
Jiangsu Hengrui Pharmaceuticals Co 600276	¥50.43	¥55.21	+9%	vs 000534
Sun Pharmaceutical Industries Limited SUNPHARMA	₹1,860	₹1,947	+5%	vs 000534
Haleon plc HLN	$9.14	$8.61	−6%	vs 000534
Merck KGaA MRK	€148.75	€109.18	−27%	vs 000534
Galderma Group GALD	CHF 191.75	CHF 109.86	−43%	vs 000534
Takeda Pharmaceutical Company TAK	$21.02	$11.31	−46%	vs 000534
Teva Pharmaceutical Industries Limited TEVA	$42.61	$20.74	−51%	vs 000534
Sandoz Group SDZ	CHF 83.78	CHF 39.70	−53%	vs 000534
Divi's Laboratories Limited DIVISLAB	₹10,321	₹1,567	−85%	vs 000534

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued High-Quality Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks Undervalued Dividend Stocks Undervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more

Run the numbers yourself: free valuation calculators

DCF Calculator P/E Ratio Calculator PEG Ratio Calculator Graham Number Peter Lynch Formula DDM Calculator Intrinsic Value Intrinsic vs Extrinsic Value P/E Ratio by Sector

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Wedge Industrial Co Ltd: fair value per Fair Value Calculator

<a href="https://www.fairvalue-calculator.com/stock/000534?utm_source=embed&amp;utm_medium=badge" target="_blank" rel="nofollow noopener"><img src="https://www.fairvalue-calculator.com/embed/000534.SHE.svg" width="360" height="84" alt="Wedge Industrial Co Ltd: fair value per Fair Value Calculator" style="border:0;max-width:100%" loading="lazy"></a>

Cite: Fair Value Calculator (2026). "Wedge Industrial Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/000534

Frequently asked questions

Is Wedge Industrial Co Ltd (000534) overvalued or undervalued?

As of Nov 5, 2026, our model estimates a fair value of ¥6.97 versus a price of ¥17.14, about 59% lower (overvalued).

What is the fair value of 000534?

Our model-based fair value for Wedge Industrial Co Ltd is ¥6.97 (as of Nov 5, 2026), built from audited fundamentals. The current price: ¥17.14.

What is the quality score of 000534?

Wedge Industrial Co Ltd has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.

What is the price target for Wedge Industrial Co Ltd (000534)?

Our model-based price target is the fair value of ¥6.97 (as of Nov 5, 2026) from 16 valuation models. Cautious scenario ¥4.82, optimistic scenario ¥9.26. It is a calculation from audited fundamentals, not an analyst target.

What is the Wedge Industrial Co Ltd stock forecast for 2026?

Our models put fair value at ¥6.97, about 59% lower versus a price of ¥17.14 (overvalued). Cautious scenario ¥4.82, optimistic scenario ¥9.26. The calculation is refreshed regularly with new filings.

What is the revenue of Wedge Industrial Co Ltd (000534)?

Wedge Industrial Co Ltd reported trailing-twelve-month revenue of about 1.3B CNY (latest available figure, as of Nov 5, 2026).

What is the intrinsic value of Wedge Industrial Co Ltd (000534)?

Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Wedge Industrial Co Ltd it is ¥6.97 per share (as of Nov 5, 2026), against a price of ¥17.14. It is the blended result of 16 valuation models in 6 families (Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).

Is Wedge Industrial Co Ltd stock overvalued or undervalued in 2026?

As of Nov 5, 2026, 000534 trades above its calculated fair value: price ¥17.14, fair value ¥6.97, a gap of about −59% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.

Is fair value the same as the market price of 000534?

No. The price is what the market pays today (¥17.14); the fair value is what the company's own numbers justify (¥6.97). For Wedge Industrial Co Ltd the two are ¥10.17 per share apart. That gap is exactly why we show both numbers side by side.

How much is Wedge Industrial Co Ltd worth?

The market values Wedge Industrial Co Ltd at about 8.8B CNY (market capitalisation, as of Nov 5, 2026). Per share that is ¥17.14; our models calculate a fair value of ¥6.97 per share.

What do the bullish and bearish scenarios say about 000534?

Our models span a range for Wedge Industrial Co Ltd: cautious scenario ¥4.82, base ¥6.97, optimistic ¥9.26 per share (as of Nov 5, 2026, price ¥17.14). The range comes from different growth and margin assumptions, not from analyst opinions.

What is the P/E ratio of 000534?

Wedge Industrial Co Ltd trades at a price-to-earnings ratio of 43.9 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥6.97 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2015 to 2024), reported earnings: 73.5. Other multiples: PEG 0.9, P/B 6.5, P/S 6.6, EV/EBITDA 34.9.

What is the PEG ratio of 000534?

The PEG ratio of Wedge Industrial Co Ltd is 0.94 (P/E divided by earnings growth, as of Nov 5, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.

How solid is the balance sheet of Wedge Industrial Co Ltd (000534)?

Balance-sheet figures for Wedge Industrial Co Ltd (as of Nov 5, 2026): return on equity 9.1%, debt of 0.81 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.

How far is 000534 from its 52-week high?

Wedge Industrial Co Ltd trades at ¥17.14, about 64% below its 52-week high of ¥47.65 and 7% above the low of ¥15.97 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ¥6.97 is for.

Which stocks are comparable to Wedge Industrial Co Ltd?

From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Galderma Group, Teva Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.

Is Wedge Industrial Co Ltd stock attractive at the current price?

The data as of Nov 5, 2026: price ¥17.14, calculated fair value ¥6.97 (−59%), Quality Score 42/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.

How is the fair value of 000534 calculated?

We run Wedge Industrial Co Ltd through 16 models from 6 families: Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥6.97 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.

Is it still worth investing in stocks now?

The global stock market currently sits 13.0% above its aggregate fair value. Wedge Industrial Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.

What is the share price of Wedge Industrial Co Ltd (000534)?

The closing price on Nov 6, 2026 was ¥17.14. Our model-based fair value is ¥6.97, about 59% lower (overvalued). We carry closing prices from our data provider, not a live tick.

What should I pay attention to with Wedge Industrial Co Ltd right now?

The price sits above even our optimistic bull case (¥9.26). The favourable scenario is already priced in. Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts. A fairly wide model range (¥4.82 to ¥9.26) leaves room in how you read the outcome.

Where does the earnings growth of Wedge Industrial Co Ltd (000534) come from?

Earnings per share at Wedge Industrial Co Ltd grew +7.4 % a year from 2013 to 2024. Broken into its drivers: revenue per share +3.3 %, EBIT margin +1.2 %, tax rate +3.1 %, residual (interest, one-offs) −0.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Wedge Industrial Co Ltd

How large is the market capitalisation of Wedge Industrial Co Ltd (000534)?

The market capitalisation of Wedge Industrial Co Ltd is 8.8B CNY (≈ $1.3B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.

What is the P/S ratio of Wedge Industrial Co Ltd (000534)?

The price-to-sales ratio of Wedge Industrial Co Ltd is 6.59 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.

What are the earnings per share of Wedge Industrial Co Ltd (000534)?

Earnings per share at Wedge Industrial Co Ltd are ¥0.3900 (price ÷ EPS = P/E 43.9). Earnings per share over the last twelve months: total profit spread across every single share.

What is the net margin of Wedge Industrial Co Ltd (000534)?

The net margin of Wedge Industrial Co Ltd is 15.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.

What is the return on equity of Wedge Industrial Co Ltd (000534)?

The return on equity (ROE) of Wedge Industrial Co Ltd is 9.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.

What is the EBIT return on assets of Wedge Industrial Co Ltd (000534)?

On an EBIT basis the return on assets of Wedge Industrial Co Ltd is 5.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.

What is the operating margin of Wedge Industrial Co Ltd (000534)?

The operating margin of Wedge Industrial Co Ltd is 14.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.

How fast is revenue growing at Wedge Industrial Co Ltd (000534)?

Revenue at Wedge Industrial Co Ltd is growing +5.7% versus a year earlier (3y avg +18.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.

How fast are earnings growing at Wedge Industrial Co Ltd (000534)?

Earnings per share at Wedge Industrial Co Ltd are growing +1.5% versus a year earlier. How much earnings per share grew versus a year earlier.

How much free cash flow does Wedge Industrial Co Ltd (000534) generate?

The free cash flow of Wedge Industrial Co Ltd is −473M CNY (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.

How much net debt does Wedge Industrial Co Ltd (000534) carry?

The net debt of Wedge Industrial Co Ltd is 1.1B CNY (fiscal year 2024). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.

Free · no account needed

Watch Wedge Industrial Co Ltd in the live analysis

One click puts Wedge Industrial Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.